Human platelet lysates (HPL), isolated from human mesenchymal stem cells, are serving an excellent alternative to fetal bovine serum (FBS). The replacement of FBS helps in the prevention of bovine prion and viral contamination, and can also represent a new therapeutic challenge in the field of stem cell therapy, increasing the demand of human platelet lysates.
The evolution of human platelet lysates has boosted various experimental and clinical research studies. Human platelet lysates do not affect functional capacities. Alternatives to FBS are human blood-derived components, namely, plasma, serum, umbilical cord blood serum, and platelet derivatives such as platelet lysates.
Multiple applications of human platelet lysates, such as research, development, and production of biotechnology and pharmaceutical drug therapies, is expected to increase the growth of human platelet lysate market.
Find Out More about the Report Coverage
- Merck KGaA
- Compass Biomedical Inc.
- Macopharma SA
- Cook Medical (Cook Regentec)
- Mill Creek Life Sciences Llc.
- Stemcell Technologies Inc.
- Zen-Bio, Inc.
- Sclavo Diagnostics International Srl.
- Life Science Group Limited (Life Science Production)
- Trinova Biochem Gmbh
Increasing Government Funding to Boost Human Platelet Lysate Market Growth
Increasing government funding for life science-related projects, and rising number of research centers and research institutes, are factors driving the growth of the human platelet lysate market. In 2013, around 59% of total research & development expenditure in the U.S. was from federal funding agencies. In 2016, 12% of federal stem cell research funding was allocated to human embryonic stem cell research.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Collaboration - Strategic Focus for Lucrative Growth Opportunities
To maximize research output, research institutes and biotech companies are collaborating for clinical trials and other research projects. Cambium Medical Technologies LLC collaborated with Massachusetts Eye and Ear Infirmary, Oregon Health and Science University, University of Michigan, and Duke University for a clinical trial of topical fibrinogen-depleted human platelet lysates in patients with dry eye secondary to graft vs. host disease.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Increasing Demand for Biopharmaceuticals to Propel Human Platelet Lysate Market
With increasing incidence of several virus- or bacteria-borne infections and diseases, the scope of biopharmaceuticals is also increasing. Monoclonal antibody (MAb) therapeutics is amongst the most dynamic and promising pipelines in the biopharmaceutical market.
Above 200 biopharmaceutical products are marketed and many more are in the development phase. Various biopharmaceutical products such as cancer vaccines, RNA interference, stem cells, cultured tissue transplants, and genes are going to be great assets for public health over the coming years.
Explore Persistence Market Research’s expertise in promulgation of the business !
A comprehensive perspective of the human platelet lysate market has led our analysts to infer that, the market is growing at a decent rate, with North America, followed by Europe, holding a large share in the global human platelet lysate market, attributable to well-developed research centers in these regions. Increasing research & developmental activities have led to the adoption of human platelet lysates in developed countries of North America and Europe. New product launches are anticipated to create more opportunities for players in the global human platelet lysate market.
Key Segments of Human platelet lysate Market
PMR’s study on the human platelet lysate market offers information divided into four important segments - product type, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Key Questions Answered in PMR’s Human Platelet Lysate Market Report
- Which regions will continue to remain the most profitable markets for human platelet lysate market players?
- Which factors will induce a change in the demand for human platelet lysate during the assessment period?
- How will changing trends impact the human platelet lysate market?
- How can market players leverage opportunities in the human platelet lysate market in developed regions?
- Which companies are leading the human platelet lysate market?
- What are the winning strategies of stakeholders in the human platelet lysate market to improve their market positions?